Enhancement of Anti-Telomerase Immunity Against Prostate Cancer

doi 10.21236/ada444923
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Enhancing Anti-Prostate Cancer Immunity Through OX40 Engagement

2006English

Immunity Against Cancer

Nature
Multidisciplinary
1969English

84PPresence of Naturally Occurring Anti-Telomerase CD4 Th1 Immunity in Glioblastoma

Annals of Oncology
MedicineOncologyHematology
2017English

A PARP Inhibitor in Pancreatic Cancer: Enhancement Anti-Tumour Activity of Chemoradiation Therapy Against Pancreatic Cancer?

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Distinct Prognostic Value of Circulating Anti-Telomerase CD4+ Th1 Immunity and Exhausted PD-1+/TIM-3+ T Cells in Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

Scoparone Exerts Anti-Tumor Activity Against DU145 Prostate Cancer Cells via Inhibition of STAT3 Activity

PLoS ONE
Multidisciplinary
2013English

Signaling Through Estrogen Receptors Modulates Telomerase Activity in Human Prostate Cancer

Journal of Clinical Investigation
Medicine
2002English

Treatment of Prostate Cancer in Vitro and in Vivo With 2-5a-Anti-Telomerase RNA Component(New Era of Antisense Therapy)

Japanese Journal of Urology
Urology
2000English

Anti-Caveolin-1 Antibodies as Anti-Prostate Cancer Therapeutics

Hybridoma
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy